Dennis E. Niewoehner

10.4k total citations · 3 hit papers
96 papers, 6.1k citations indexed

About

Dennis E. Niewoehner is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Dennis E. Niewoehner has authored 96 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 29 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Dennis E. Niewoehner's work include Chronic Obstructive Pulmonary Disease (COPD) Research (67 papers), Respiratory Support and Mechanisms (36 papers) and Asthma and respiratory diseases (24 papers). Dennis E. Niewoehner is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (67 papers), Respiratory Support and Mechanisms (36 papers) and Asthma and respiratory diseases (24 papers). Dennis E. Niewoehner collaborates with scholars based in United States, United Kingdom and Germany. Dennis E. Niewoehner's co-authors include Jerome Kleinerman, John R. Hoidal, Kathryn Rice, Dorothea Collins, Charlene McEvoy, Marcia L. Erbland, Robert H. Deupree, Nancy A. Morgan, Richard W. Light and Paula Anderson and has published in prestigious journals such as Science, New England Journal of Medicine and Annals of Internal Medicine.

In The Last Decade

Dennis E. Niewoehner

94 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathologic Changes in the Peripheral Airways of Young Cigarette Smokers

1974 712 citations Dennis E. Niewoehner et al. profile →
Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease

1999 589 citations Dennis E. Niewoehner, Dorothea Collins et al. profile →
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

2013 402 citations Dennis E. Niewoehner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dennis E. Niewoehner United States	40	4.8k	2.3k	552	444	397	96	6.1k
José Luís López-Campos Spain	34	3.9k 0.8×	1.6k 0.7×	554 1.0×	421 0.9×	335 0.8×	330	5.3k
S. F. Paul Man Canada	33	2.6k 0.5×	1.7k 0.7×	354 0.6×	564 1.3×	198 0.5×	93	4.1k
Lisa Edwards United States	39	6.4k 1.3×	3.5k 1.5×	509 0.9×	376 0.8×	167 0.4×	113	7.5k
Juan P. de‐Torres Spain	43	6.0k 1.2×	2.1k 0.9×	619 1.1×	347 0.8×	449 1.1×	177	7.3k
Sidney S. Braman United States	31	5.2k 1.1×	3.9k 1.7×	652 1.2×	264 0.6×	179 0.5×	93	7.3k
Richard Wood‐Baker Australia	41	3.1k 0.6×	1.6k 0.7×	930 1.7×	274 0.6×	326 0.8×	156	4.8k
Courtney Crim United States	40	7.0k 1.5×	3.5k 1.5×	599 1.1×	290 0.7×	190 0.5×	123	7.9k
Víctor Pinto-Plata United States	44	6.8k 1.4×	2.5k 1.1×	652 1.2×	417 0.9×	213 0.5×	106	7.9k
Gene Colice United States	45	5.2k 1.1×	4.0k 1.7×	617 1.1×	212 0.5×	358 0.9×	227	7.9k
Chin Kook Rhee South Korea	35	3.3k 0.7×	1.9k 0.8×	662 1.2×	429 1.0×	431 1.1×	332	5.2k

Countries citing papers authored by Dennis E. Niewoehner

Since Specialization

Citations

This map shows the geographic impact of Dennis E. Niewoehner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis E. Niewoehner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis E. Niewoehner more than expected).

Fields of papers citing papers by Dennis E. Niewoehner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis E. Niewoehner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis E. Niewoehner. The network helps show where Dennis E. Niewoehner may publish in the future.

Co-authorship network of co-authors of Dennis E. Niewoehner

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis E. Niewoehner. A scholar is included among the top collaborators of Dennis E. Niewoehner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis E. Niewoehner. Dennis E. Niewoehner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martínez, Fernando J., Jørgen Vestbo, Julie A. Anderson, et al.. (2016). Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction. American Journal of Respiratory and Critical Care Medicine. 195(7). 881–888. 39 indexed citations

Donohue, James F., Dennis E. Niewoehner, Jean Brooks, Dianne M. O’Dell, & Alison Church. (2013). Long-term safety and tolerability of umeclidinium/vilanterol and umeclidinium in COPD. European Respiratory Journal. 42(Suppl 57). P760–P760. 3 indexed citations

Niewoehner, Dennis E., Lorcan McGarvey, Alan Hamilton, et al.. (2013). Pooled Safety Analysis of Olodaterol Once Daily via Respimat® Versus Placebo and Formoterol Twice Daily in Patients With COPD: Independently Adjudicated Respiratory-Related Serious Adverse Events. CHEST Journal. 144(4). 712A–712A. 1 indexed citations

Kunisaki, Ken M., Dennis E. Niewoehner, & John E. Connett. (2011). Vitamin D Levels and Risk of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study. American Journal of Respiratory and Critical Care Medicine. 185(3). 286–290. 76 indexed citations

Hanania, Nicola A., et al.. (2010). Triple Therapy of Fluticasone Propionate/Salmeterol Combination 250/50 mcg and Tiotropium Improves Lung Function Compared to Tiotropium Monotherapy. CHEST Journal. 138(4). 867A–867A. 2 indexed citations

Rice, Kathryn, Naresh A. Dewan, Hanna E. Bloomfield, et al.. (2010). Disease Management Program for Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 182(7). 890–896. 212 indexed citations

Niewoehner, Dennis E., Yuliya Lokhnygina, Kathryn Rice, et al.. (2007). Risk Indexes for Exacerbations and Hospitalizations Due to COPD. CHEST Journal. 131(1). 20–28. 146 indexed citations

Kunisaki, Ken M., Kathryn Rice, & Dennis E. Niewoehner. (2007). Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Elderly. Drugs & Aging. 24(4). 303–324. 8 indexed citations

Niewoehner, Dennis E.. (2002). Impact of drug classes used in COPD on outcome measures other than exacerbations. European Respiratory Review. 12(82). 11–12. 3 indexed citations

10.

Niewoehner, Dennis E.. (2002). The Role of Systemic Corticosteroids in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. PubMed. 1(4). 243–248. 30 indexed citations

11.

Niewoehner, Dennis E.. (2001). Role of corticosteroids in acute exacerbations of chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine. 7(2). 75–78. 1 indexed citations

12.

Rice, Kathryn, Jeffrey B. Rubins, Connie M. Parenti, et al.. (2000). Withdrawal of Chronic Systemic Corticosteroids in Patients with COPD. American Journal of Respiratory and Critical Care Medicine. 162(1). 174–178. 59 indexed citations

13.

Niewoehner, Dennis E. & Dorothea Collins. (2000). Relation of FEV1 to Clinical Outcomes during Exacerbations of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 161(4). 1201–1205. 72 indexed citations

14.

McEvoy, Charlene, et al.. (1998). Association between Corticosteroid Use and Vertebral Fractures in Older Men with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 157(3). 704–709. 218 indexed citations

15.

Niehans, Gloria A., Jeffrey B. Rubins, José Jessurun, et al.. (1998). Do Molecular Markers Predict Survival in Non–Small-Cell Lung Cancer?. American Journal of Respiratory and Critical Care Medicine. 157(4). 1093–1097. 86 indexed citations

16.

McEvoy, Charlene & Dennis E. Niewoehner. (1997). Adverse Effects of Corticosteroid Therapy for COPD. CHEST Journal. 111(3). 732–743. 123 indexed citations

17.

Rice, Kathryn, Richard S. Kronenberg, Linda L. Hedemark, & Dennis E. Niewoehner. (1987). Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. British Journal of Diseases of the Chest. 81(3). 287–292. 57 indexed citations

18.

Davies, Scott F., et al.. (1983). Urine Desmosine is Unrelated to Cigarette Smoking or to Spirometric Function. American Review of Respiratory Disease. 128(3). 473–475. 36 indexed citations

19.

Hale, Kathryn, Dennis E. Niewoehner, & Manuel G. Cosío. (1980). Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema.. PubMed. 122(2). 273–8. 88 indexed citations

20.

Niewoehner, Dennis E., et al.. (1977). Effect of ouabain on the transmucosal potential difference in the intact canine airway. Clinical research. 25(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact